checkAd

    @@@@@NANOSIGNAL@@@@@ - 500 Beiträge pro Seite

    eröffnet am 12.02.04 09:25:43 von
    neuester Beitrag 12.02.04 14:21:41 von
    Beiträge: 8
    ID: 820.064
    Aufrufe heute: 0
    Gesamt: 762
    Aktive User: 0


     Durchsuchen

    Begriffe und/oder Benutzer

     

    Top-Postings

     Ja Nein
      Avatar
      schrieb am 12.02.04 09:25:43
      Beitrag Nr. 1 ()
      DIE NEUE TOPRAKETE STARTET :kiss:
      Avatar
      schrieb am 12.02.04 09:35:48
      Beitrag Nr. 2 ()
      :lick: :cool: :lick: :cool: :lick: :cool: :lick: :cool:

      Einfach nur lecker......
      Avatar
      schrieb am 12.02.04 11:17:17
      Beitrag Nr. 3 ()
      Wenn wir mal heute abend nicht bei 0.30 € stehen.. :laugh: :laugh: :laugh: :laugh:
      Avatar
      schrieb am 12.02.04 13:05:30
      Beitrag Nr. 4 ()
      ...so siehst du aus...geile verarsche.
      Avatar
      schrieb am 12.02.04 13:28:41
      Beitrag Nr. 5 ()
      Brasileiro Will billig rein:D

      Trading Spotlight

      Anzeige
      InnoCan Pharma
      0,1865EUR 0,00 %
      Multi-Milliarden-Wert in diesem Pennystock?!mehr zur Aktie »
      Avatar
      schrieb am 12.02.04 13:31:42
      Beitrag Nr. 6 ()
      nix da mit billig rein.



      sorry leute, das ist kein bashing (bin auch nicht investiert) aber was ist denn an news gekommen???

      sie dürfen testen lassen, mehr nicht. und wo? in der gleichen stadt in einigen minihospitälern.
      (http://www.desertrad.com/intro.html)

      so zum beispiel:

      DESERT SPRINGS HOSPITAL
      2075 EAST FLAMINGO ROAD
      LAS VEGAS, NV 89119

      SHORT TERM HOSPITALS


      Beds - Total (Total number of beds in a facility, including those in non-Participating or non-licensed areas): 346

      Beds - Total certified (Number of beds in Medicare and/or Medicaid certified areas within a facility): 346

      Physicians (The number of full-time equivalent physicians employed by a provider): 1

      Change of ownership counter (The number of times a change of ownership (chow) has taken place for a particular provider): 3

      tolle nummer, echt.
      Avatar
      schrieb am 12.02.04 13:39:47
      Beitrag Nr. 7 ()
      @6 Hast Du andere News als wir?


      Alle Foren- - - - - - - - - - - - - - - - - - - - - - - -AdHocAktie im FokusAllgemeinesAsienAuslandswerteforumAustralienBiotech-AktienBoardtreffenBreitband/Medien/i-TVCharttechnikDAX/MDAXDaytrader/FuturesDepotbesprechungDie 50-erDow Jones / NasdaqEinsteigerforumEuropaEx-SAC-ForumFinanzsoftwareFinanzstrategienFondsFundamentalanalyseGeschlossene FondsGold-AktienGrüne AktienHot StocksImmobilienInformationsquellenInternat. WährungenInternetInvestmentclubsKarriereKaufempfehlungKreditelive:traderMakleraktienNanotechnologieNeuemissionenNeuer MarktNeuer Markt (reg.)OptionsscheineOptionsscheine (reg.)OsteuropaOTC-BBRecht & SteuernRenten/GeldanlagenSchweizSMAX / NebenwerteSport & MotorTecDAXTelekommunikationVerkaufsempfehlungVersicherungenVorbörsliche Wertew:o Feedbackw:o Newsw:o trading GmbHwallstreet:sofawallstreet:sofa (reg.)Wirtschaft & Politik (reg.)ZertifikateÖsterreich Boardsuche nach: Art: StichwortAktieUserThread-Nr. Zeitraum: Heuteletzte Wocheletzter Monatletztes Halbjahrletztes JahrAlle

      Suche nach Werten Ihrer Portfolios: keine Positionen vorhanden Zeitraum: Heuteletzte Wocheletzter Monatletztes Halbjahrletztes JahrAlle




      Thema: $$$ UNGLAUBLICHE NEWS nachbörslich bei NANOSIGNAL $$$ [Thread-Nr.: 820049]

      Tools Informationen zum Thread Navigation
      Kompletten Thread zeigen
      In Favoriten aufnehmen (mit Alarm)
      Zurück zur Suche
      Aktualisieren

      Antwort schreiben Beiträge:
      Gelesen gesamt:
      Gelesen heute:
      Thread eröffnet von:
      Erstes Posting:
      Letztes Posting: 46
      2124
      2124
      toptiper
      12.02.04 09:12
      12.02.04 13:27 AdHocAktie im FokusAllgemeinesAsienAuslandswerteforumAustralienBiotech-AktienBoardtreffenBreitband/Medien/i-TVCharttechnikDAX/MDAXDaytrader/FuturesDepotbesprechungDie 50-erDow Jones / NasdaqEinsteigerforumEuropaEx-SAC-ForumFinanzsoftwareFinanzstrategienFondsFundamentalanalyseGeschlossene FondsGold-AktienGrüne AktienHot StocksImmobilienInformationsquellenInternat. WährungenInternetInvestmentclubsKarriereKaufempfehlungKreditelive:traderMakleraktienNabil KhayatNanotechnologieNeuemissionenNeuer MarktNeuer Markt (reg.)OptionsscheineOptionsscheine (reg.)OsteuropaOTC-BBRecht & SteuernRenten/GeldanlagenSchweizSMAX / NebenwerteSport & MotorTecDAXTelekommunikationVerkaufsempfehlungVersicherungenVorbörsliche Wertew:o Feedbackw:o Newsw:o trading GmbHwallstreet:sofawallstreet:sofa (reg.)Wirtschaft & Politik (reg.)ZertifikateÖsterreich

      Seitennavigation: | 1 2 3


      #1 von toptiper 12.02.04 09:12:48 Beitrag Nr.: 12.128.173 12128173
      Dieses Posting: versenden | melden | drucken | Antwort schreiben NANOSIGNAL CORPORATION

      Ich habe NNOS schon eine Weile auf der Watchlist - dann schaue ich heute morgen mal wieder bei Yahoo rein und dann sehe ich dies

      Vorneweg der CEO:
      " We are no longer a start-up company, but a real contender for a share of the multi-million dollar MRI industry. "


      Hier die News:

      NanoSignal Corp. -- Formerly MicroSignal -- Reports Successful Beta Testing Results of SLICES, Sales & Marketing and Other Significant Developments
      Wednesday February 11, 11:47 pm ET


      LAS VEGAS--(BUSINESS WIRE)--Feb. 11, 2004--NanoSignal Corp. (formerly Microsignal Corp.) (OTCBB:NNOS - News) reported today the highly successful and industry significant completion of the first phase of beta testing of SLICES(TM) software technology for MRI devices at Desert Radiology in Las Vegas, NV.
      ADVERTISEMENT


      Dr. Lawrence Madoff, President of NanoSignal, reported that " the beta test results at Desert Radiology are historic not only for NanoSignal but for the MRI industry as a whole. With the help of Dr. Jeffrey Taft, Ph.D., who is the inventor and founder of SLICES(TM), we have been able to prove-up our technology in the field. We are no longer a start-up company, but a real contender for a share of the multi-million dollar MRI industry.

      " Working with a standard 1.5 Tesla General Electric MRI scanner at Desert Radiology, we used SLICES(TM) to maintain signal noise and resolution in less than 50% of the usual scanning time while at the same time producing clear images suitable for radiological interpretation. This achievement is industry historic since it demonstrates that SLICES(TM) software not only works but works in half of the time. This means that patient pass through is increased resulting in medical cost savings and greater human comfort since time in the tunnel can be greatly shortened."

      Our engineering team will continue beta testing at Desert Radiology over the next several weeks on both GE and other MRI devices manufactured by the leading companies in the business. Our objectives will be to increase resolution and improve image quality on all MRI devices, both tunnel configuration and the highly popular open MRI`s. Testing of SLICES(TM) integration with DICOM compatible PACS systems is progressing with a high degree of satisfaction. Significantly, our technical " White Paper" will include both the beta test results for SLICES(TM), a marketing plan, financial forecasts and statistical data for health insurers proving the cost benefits of SLICES(TM). We will be assisted by Ali Noshirvani, who has been selected to head-up sales and marketing, as previously announced in our Business Wire press release dated Feb. 5, 2004. We further anticipate ramping up a recruitment program for additional software engineers and installation technicians.

      With beta testing near completion, our message to the MRI industry is that up-grading MRI devices with the new SLICES(TM) software versus the capital outlay for costlier MRI equipment is now a real choice. Given the size and depth of the MRI industry, we are open to multiple distribution channels such as direct sales, co-branding, sub-licensing and strategic alliances with MRI manufacturers. The best thing for our shareholders is to make SLICES(TM) the software of choice for all MRI manufacturers to replace the outdated image processing methodologies that is decades old. Everyone knows how successful " red eye" reduction has been to the camera and film industry. Now with SLICES(TM), MRI facilities have a one stop purchase to reduce artifacts and ghosting on images with increased productivity that pays for the software outlay.

      The company has been in negotiations with multiple investment banking firms to meet its anticipated funding needs for national and international sales and marketing in 2004-2005. In order to concentrate on the beta testing and the medical applications of SLICES(TM), Dr. Madoff will continue as President of NanoSignal with the additional title of Chief Operating Officer. The Board of Directors and majority preferred shareholder have unanimously selected Scott Ervin to take on the responsibilities of Chief Executive Officer. Scott is a welcome member of the NanoSignal team and he will be instrumental in meeting the global demand for SLICES(TM).

      Scott Erwin has enjoyed an impressive career in real estate management, finance, mergers-acquisitions and leasing with a number Fortune 500 caliber companies including the First Boston Corporation, Fisher Brothers, and Rockefeller Center, Inc. In November 2003, Mr. Erwin became President and CEO of Micro Bio-Medical Systems, Inc., a position which he will continue to hold indefinitely.

      Additional information regarding SLICES(TM) and NanoSignal Corp. is available at www.nanosignalcorp.com.

      This press release contains " forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements can be identified by the lead-in " Looking Forward." These statements are not guarantees of future performance and involve significant risks and uncertainties. Actual results may vary materially from those in the forward-looking statements as a result of the effectiveness of management`s strategies and decisions, general economic and business conditions, new or modified statutory or regulatory requirements, and changing price and market conditions. No assurance can be given that these are all the factors that could cause actual results to vary materially from the forward-looking statement.




      :confused:
      Avatar
      schrieb am 12.02.04 14:21:41
      Beitrag Nr. 8 ()
      NNOS: Completes Beta Testing for SLICES(TM) MRI Software [delayed]

      Ridgeland, MS, FEB 12, 2004 (EventX/Knobias.com via COMTEX) -- NanoSignal Corp. (NNOS) reported the highly successful completion of the first phase of beta testing of SLICES(TM) software technology for MRI devices at Desert Radiology in Las Vegas, NV. Working with a standard 1.5 Tesla General Electric MRI scanner, The Company used SLICES(TM) to maintain signal noise and resolution in less than 50% of the usual scanning time while at the same time producing clear images suitable for radiological interpretation.

      GET KNOBIAS IN REAL-TIME: Delivery of this proprietary Knobias alert has been delayed by at least 10 minutes. To get all Knobias alerts in real-time daily, visit www.knobias.com/cmtx

      ABOUT KNOBIAS: Knobias is a premier financial information provider of trading and investing data covering all U.S. equities for investors and security professionals. Knobias is best described by its three major components: Real-time desktop applications providing quotes, charts, level 2, analysis etc.; Knobias RAiDAR providing thousands of real-time news stories, alerts and documents daily; Knobias fundamentals providing a comprehensive database of fundamental research information.


      CONTACT: Knobias.com, LLC
      601-978-3399
      601-978-3675
      info@knobias.com
      www.knobias.com/cmtx



      Copyright 2004 Knobias.com, LLC, All rights reserved.

      -0-


      Beitrag zu dieser Diskussion schreiben


      Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
      Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie
      hier
      eine neue Diskussion.
      @@@@@NANOSIGNAL@@@@@